Agenda and Related Documents

• November 16-17, 2009: Blood Products Advisory Committee Meeting Draft Agenda (PDF - 30KB) 
• November 16-17, 2009: Blood Products Advisory Committee Meeting Draft Committee Roster (PDF - 52KB) 
• November 16-17, 2009: Blood Products Advisory Committee Meeting References (PDF - 45KB) 
• November 16-17, 2009: Blood Products Advisory Committee Meeting: FDA Issue Summary for Topic 1 (Final Issue Summary Malaria) (PDF - 170KB) 
• November 16-17, 2009: Blood Products Advisory Committee Meeting: FDA Issue Summary for Topic 3 (Final BPAC Nov 2009 BP and Pulse) (PDF - 284KB) 
• November 16-17, 2009: Blood Products Advisory Committee Meeting: FDA Issue Summary for Topic 4 (Topic 4 Issue Summary Final) (PDF - 51KB) 

Other Briefing Documents

Persons with disabilities having problems accessing the pdf file below may call 301-827-0314 for assistance.

• November 16-17, 2009: Blood Products Advisory Committee Meeting: A Phase 3 Prospective, Randomized, Double-Blinded, Multicenter Clinical Trial to Determine Effectiveness and Safety of Platelet Components Prepared by Photochemical Treatment Compared to Conventional Components Processes (PDF - 5915KB) 
• November 16-17, 2009: Blood Products Advisory Committee Meeting: FDA Issue Summary for Topic 2 (Study Designs (Phases 3 and 4) for Product Development of Human Platelets Using the Cerus INTERCEPT Blood System for Pathogen Inactivation) (PDF - 388KB)